RT Journal Article
SR Electronic
T1 Harnessing digital tools for the management of large-scale larviciding operations: a pilot of the ZzappMalaria software system in Obuasi, Ghana
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2024.03.07.24303784
DO 10.1101/2024.03.07.24303784
A1 Williams, Ignatius
A1 Desewu, Kwame
A1 Asiedu, Samuel
A1 Ato Egyir, Nicholas
A1 Gluck, Dan
A1 Houri-Yafin, Arnon
A1 Fialkoff, Yonata
A1 Vigodny, Arbel
YR 2024
UL http://medrxiv.org/content/early/2024/03/09/2024.03.07.24303784.abstract
AB Larval source management (LSM) has played a critical role in historical malaria elimination endeavors, yet its application in tropical settings has been hampered by operational hurdles and limited effectiveness. To address these issues, ZzappMalaria Ltd. developed a digital platform for the planning and implementation of LSM campaigns, the features and field efficacy of which are discussed in this paper.Piloted in collaboration with AngloGold Ashanti Malaria Control Ltd. (AGAMal) in Obuasi, Ghana, the system, comprising a planning tool, a mobile app for fieldworkers and an online dashboard for monitoring and worker management, facilitated the detection of more than 4,000 water bodies and reduced the mosquito population by 62% for a cost of $0.24 per person protected (PPP). The data available does not provide sufficient evidence to conclusively determine whether a reduction in malaria cases occurred; nevertheless, the results underscore the potential of digitization to surmount the operational challenges of large-scale LSM campaigns.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe operation was funded by ZzappMalaria Ltd. and AngloGold Ashanti Malaria Control Ltd. (AGAMal)Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was a collaboration between Zzapp Malaria Ltd. and AngloGold Ashanti Malaria Control Ltd. (AGAMal), and evaluated data collected by AGAMal who received an ethical approval from the Ghana Health Service Ethics Review Committee to perform malaria control interventions in the applicable area and collect and analyze relevant data. In addition, this was an operational study and did not involve collection of subject related data.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.YesAll data produced in the present study are available upon reasonable request to the authors